Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: results from the PURSUIT trial

Additional Metadata
Keywords	0 (Peptides), 0 (Platelet Aggregation Inhibitors), 0 (eptifibatide), Atrial Fibrillation/drug therapy/etiology/mortality, Cerebrovascular Accident/etiology/mortality, Double-Blind Method, Female, Hazards Models, Human, Male, Myocardial Ischemia/*complications/drug therapy, Non-U.S. Gov't, Peptides/therapeutic use, Platelet Aggregation Inhibitors/therapeutic use, Support, Survival Analysis, Treatment Outcome
Persistent URL	doi.org/10.1016/S0002-9149(01)01593-4, hdl.handle.net/1765/5659
Journal	The American Journal of Cardiology
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Al-Khatib, S., Pieper, K., Lee, K., Mahaffey, K., Hochman, J., Pepine, C., … Akkerhuis, M. (2001). Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: results from the PURSUIT trial. The American Journal of Cardiology, 88(1), 76–79. doi:10.1016/S0002-9149(01)01593-4

Publication